Our mission is to triple the pancreatic cancer survival rate by 2030 and significantly improve the quality of life for those impacted by the disease.

 

Together with our partners and community, we’re confronting pancreatic cancer head-on. Making progress a reality through groundbreaking research, compassionate support, and tireless advocacy. Because when the stakes are this high, action isn’t just important—it’s essential and urgent.

 

Pancreatic cancer is the toughest common cancer, and for too long, progress has lagged behind. Survival rates have barely improved in decades, leaving people diagnosed feeling overwhelmed and uncertain. We’re determined to change this. We are the only Australian organisation solely dedicated to improving outcomes for those affected by pancreatic cancer.

 

Join the fight Our Approach

We are investing in Australia's top researchers.

Achievements

flask-icon
Invested over $14 million into pancreatic cancer research
write-icon
Lead funder of strategic, Early Detection research projects
walk-icon
United over 30,000 Australians at our national walks
ribbon-icon
Driving the agenda and raising awareness of the disease nationwide

Latest news

How Dr Andrew Lowy’s global expertise keeps the focus where it’s needed most

Feb 17 2025

Dr Andrew Lowy, Chief of Surgical Oncology at Moores Cancer Center, University of California, San Diego, is an internationally renowned surgeon and scientist. As a member of Pankind’s Scientific Advisory Panel, he plays a key role in shaping our research strategy and has shared some of his key findings at our annual Scientific Meetings.

Read story ➞
All news